Stocklytics Platform
Asset logo for symbol KIDS
OrthoPediatrics
KIDS51
$20.78arrow_drop_down1.51%-$0.32
Asset logo for symbol KIDS
KIDS51

$20.78

arrow_drop_down1.51%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

OrthoPediatrics (KIDS) Stocklytics Forecast

OrthoPediatrics Corp (KIDS) is a leading global orthopedic company focused exclusively on providing pediatric surgical solutions. With a mission to improve the lives of children with orthopedic conditions, KIDS offers a comprehensive product portfolio designed specifically for the unique needs of pediatric patients. The company's innovative implants, instruments, and biologics are used by surgeons worldwide to treat a wide range of pediatric orthopedic conditions, including scoliosis, limb deformities, and trauma.
In terms of stock price prediction, it is important to note that forecasting the future performance of any stock involves a certain level of uncertainty. However, analysts and market experts have provided their insights on OrthoPediatrics Corp's (KIDS) stock price forecast. According to these predictions, the company's stock is expected to experience significant growth in the coming years. By 2023, the stock price is expected to reach a target of $X, representing a Y% increase from the current price.
add OrthoPediatrics to watchlist

Keep an eye on OrthoPediatrics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for OrthoPediatrics (KIDS) stock?

Analysts have set a target price of $48.63 for OrthoPediatrics (KIDS), based on forecasts from 30 analysts. The predicted price range extends from a high of $66 to a low of $31. This represents a potential increase of up to 217.54% and a decrease of 49.15% from the current price of $20.79. These forecasts are as of 2022 Jul 18.
help

What are the analyst ratings for OrthoPediatrics (KIDS) stock?

The analyst ratings for OrthoPediatrics (KIDS) are distributed as follows: 6 analysts recommend buying, 1 have a neutral stance, and 0 suggest selling. The prevailing sentiment among the total of 7 analysts leans towards a buy rating. These ratings indicate the general sentiment among the analysts covering OrthoPediatrics.
help

What is the AI price prediction for OrthoPediatrics (KIDS) stock?

At present, there is no AI or machine-learning-based price prediction available for OrthoPediatrics (KIDS) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level